Nephros Inc (NEPH)
2.19
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
2.20
+0.01
(+0.46%)
After-Hours: 20:00
Nephros SG&A Expense (Quarterly): 2.411M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.411M |
September 30, 2023 | 2.137M |
June 30, 2023 | 2.239M |
March 31, 2023 | 2.124M |
December 31, 2022 | 1.787M |
September 30, 2022 | 1.743M |
June 30, 2022 | 1.885M |
March 31, 2022 | 2.177M |
December 31, 2021 | 1.822M |
September 30, 2021 | 1.718M |
June 30, 2021 | 1.854M |
March 31, 2021 | 1.999M |
December 31, 2020 | 1.362M |
September 30, 2020 | 1.544M |
June 30, 2020 | 1.61M |
March 31, 2020 | 1.95M |
December 31, 2019 | 1.426M |
September 30, 2019 | 1.787M |
June 30, 2019 | 1.403M |
March 31, 2019 | 1.503M |
December 31, 2018 | 1.097M |
September 30, 2018 | 1.069M |
June 30, 2018 | 1.091M |
March 31, 2018 | 1.26M |
December 31, 2017 | 0.893M |
Date | Value |
---|---|
September 30, 2017 | 0.753M |
June 30, 2017 | 0.88M |
March 31, 2017 | 0.77M |
December 31, 2016 | 0.62M |
September 30, 2016 | 0.652M |
June 30, 2016 | 0.804M |
March 31, 2016 | 0.777M |
December 31, 2015 | 0.892M |
September 30, 2015 | 0.974M |
June 30, 2015 | 0.735M |
March 31, 2015 | 0.843M |
December 31, 2014 | 0.693M |
September 30, 2014 | 0.765M |
June 30, 2014 | 0.70M |
March 31, 2014 | 0.711M |
December 31, 2013 | 0.776M |
September 30, 2013 | 0.578M |
June 30, 2013 | 0.66M |
March 31, 2013 | 1.055M |
December 31, 2012 | 1.056M |
September 30, 2012 | 1.006M |
June 30, 2012 | 0.838M |
March 31, 2012 | 0.72M |
December 31, 2011 | 0.704M |
September 30, 2011 | 0.574M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.362M
Minimum
Dec 2020
2.411M
Maximum
Dec 2023
1.841M
Average
1.822M
Median
Dec 2021
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |